BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2011
View Archived Issues
Long-term safety and efficacy reported from teriflunomide trial TEMSO in relapsing MS
Read More
Quadrivalent influenza vaccine is safe and immunogenic in older subjects
Read More
First-in-human data on PET tracer BAY-86-9596
Read More
Duloxetine may hold promise as therapy for MS-related central neuropathic pain
Read More
Novel transient receptor potential TRPV4 channel antagonists prepared by GSK
Read More
MediciNova begins phase Ib trial to test repeat dosing of MN-221 in COPD
Read More
St. Jude Medical diagnostic technology cleared for use in U.S.
Read More
Eviendep may alter neoproliferative processes in intestinal mucosa
Read More
Eli Lilly discloses new cannabinoid CB2 receptor agonists
Read More
Novel tachykinin NK3 receptor antagonists claimed by Euroscreen
Read More
Novel diacylglycerol O-acyltransferase type 1 inhibitors synthesized by AstraZeneca
Read More
Palobiofarma prepares novel adenosine A2A receptor antagonists
Read More
Amsterdam Molecular Therapeutics announces restructuring
Read More
Acceleron Pharma begins phase II trial of ACE-041 in head and neck cancer
Read More
New phase Ib/II study of BEZ-235 launched
Read More
Pfizer completes acquisition
Read More
FDA grants new orphan drug status to BioVaxID
Read More
Discussions regarding Biotie's planned acquisition of Newron terminated
Read More
Alcon Research begins recruitment in phase I trial of nasal spray solution for allergies
Read More
The Medicines Company and Daiichi Sankyo to copromote anticoagulant in Germany
Read More
Biogen Idec and Portola enter collaboration for SYK inhibitors
Read More
Oxford BioMedica and Mayo Clinic to collaborate on gene therapy for chronic glaucoma
Read More
BerGenBio begins preclinical development of lead product
Read More
Trophos cardioprotectant enters proof-of-concept phase II trial
Read More